Immune cell therapy takes on tough lupus cases
NCT ID NCT06265220
First seen Dec 17, 2025 · Last updated May 18, 2026 · Updated 17 times
Summary
This early-stage study tests a new treatment called AB-101, made from natural killer cells, for people with severe lupus that hasn't responded to standard therapies. The treatment is given alone or with a B-cell depleting antibody to try to control the disease. The main goals are to check safety and see if it helps reduce lupus activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Artiva Investigational Site Aventura
Aventura, Florida, 33180, United States
-
Artiva Investigational Site Birmingham
Birmingham, Alabama, 35249, United States
-
Artiva Investigational Site Charlotte
Charlotte, North Carolina, 28625, United States
-
Artiva Investigational Site Iowa
Iowa City, Iowa, 52242, United States
-
Artiva Investigational Site Mesquite
Mesquite, Texas, 75150, United States
-
Artiva Investigational Site Plantation
Plantation, Florida, 33324, United States
-
Artiva Investigational Site San Diego
San Diego, California, 92121, United States
-
Artiva Investigational Site Tucson
Tucson, Arizona, 85724, United States
-
Artiva Investigational Site Woodlands
The Woodlands, Texas, 77382, United States
Conditions
Explore the condition pages connected to this study.